Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matjaz Rokavec

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Cell Death & Disease|April 21, 2026
TGF-β/SMAD4/14-3-3σ/TFEB axis promotes mesenchymal-epithelial transition and inhibits autophagy in colorectal cancerXiaoyan Chen, Markus Winter, Matjaz Rokavec, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 19, 2020
Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal CancerXiaolong Shi, Markus Kaller, Matjaz Rokavec, et al.
Cell Death and Differentiation|October 18, 2024
Myeloid Mir34a suppresses colitis-associated colon cancer: characterization of mediators by single-cell RNA sequencingJanine König, Matjaz Rokavec, Meryem Gülfem Öner-Ziegler, et al.
Gastroenterology|August 13, 2018
Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1Meryem Gülfem Öner, Matjaz Rokavec, Markus Kaller, et al.
Plos One|July 19, 2014
ERBB4 promoter polymorphism is associated with poor distant disease-free survival in high-risk early breast cancerKari J Kurppa, Matjaz Rokavec, Maria Sundvall, et al.
Cancer Research|December 3, 2008
A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancerMatjaz Rokavec, Werner Schroth, Sandra M C Amaral, et al.
Science China. Life Sciences|April 2, 2024
Cytokines-activated nuclear IKKα-FAT10 pathway induces breast cancer tamoxifen-resistanceXueyan Chen, Weilin Wu, Ji-Hak Jeong, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 15, 2025
Five-Gene Expression Signature Associated With Acquired FOLFIRI Resistance and Survival in Metastatic Colorectal CancerElise Pretzsch, Christiane A Peschel, Matjaz Rokavec, et al.
Cancer Research|October 11, 2022
SMAD4 Loss Induces c-MYC-Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and MetastasisLeon P Loevenich, Markus Tschurtschenthaler, Matjaz Rokavec, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
A novel polymorphism in the promoter region of ERBB4 is associated with breast and colorectal cancer riskMatjaz Rokavec, Christina Justenhoven, Werner Schroth, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Cell Death & Disease|April 21, 2026
TGF-β/SMAD4/14-3-3σ/TFEB axis promotes mesenchymal-epithelial transition and inhibits autophagy in colorectal cancerXiaoyan Chen, Markus Winter, Matjaz Rokavec, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 19, 2020
Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal CancerXiaolong Shi, Markus Kaller, Matjaz Rokavec, et al.
Cell Death and Differentiation|October 18, 2024
Myeloid Mir34a suppresses colitis-associated colon cancer: characterization of mediators by single-cell RNA sequencingJanine König, Matjaz Rokavec, Meryem Gülfem Öner-Ziegler, et al.
Gastroenterology|August 13, 2018
Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1Meryem Gülfem Öner, Matjaz Rokavec, Markus Kaller, et al.
Plos One|July 19, 2014
ERBB4 promoter polymorphism is associated with poor distant disease-free survival in high-risk early breast cancerKari J Kurppa, Matjaz Rokavec, Maria Sundvall, et al.
Cancer Research|December 3, 2008
A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancerMatjaz Rokavec, Werner Schroth, Sandra M C Amaral, et al.
Science China. Life Sciences|April 2, 2024
Cytokines-activated nuclear IKKα-FAT10 pathway induces breast cancer tamoxifen-resistanceXueyan Chen, Weilin Wu, Ji-Hak Jeong, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 15, 2025
Five-Gene Expression Signature Associated With Acquired FOLFIRI Resistance and Survival in Metastatic Colorectal CancerElise Pretzsch, Christiane A Peschel, Matjaz Rokavec, et al.
Cancer Research|October 11, 2022
SMAD4 Loss Induces c-MYC-Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and MetastasisLeon P Loevenich, Markus Tschurtschenthaler, Matjaz Rokavec, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
A novel polymorphism in the promoter region of ERBB4 is associated with breast and colorectal cancer riskMatjaz Rokavec, Christina Justenhoven, Werner Schroth, et al.
Pageof 4